
    
      To confirm the feasibility of studying Xtampza ER during radiotherapy (RT) for locally
      advanced head and neck cancer (LAHNC) as part of a prospective clinical trial. Investigators
      will also assess pain control, quality of life, and drug related toxicity during RT and
      during short term follow-up.
    
  